skip to content

Department of Pharmacology

 
Author(s): 
Bulmer, DCE, Coelho, AM, Winchester, WJ
Abstract: 

Great advances have been made in the past decade in our understanding of visceral pain, in particular irritable bowel syndrome (IBS). As a consequence of these breakthroughs, a number of mechanistically differing, therapeutic treatments are currently available or in clinical trials. Experimental medicine studies on compounds in development provide favourable early indications that these therapies may show efficacy for the treatment of visceral pain and suggest a promising future for many patients that currently suffer with visceral pain syndromes. © 2008 Elsevier Ltd.

Publication ID: 
914800
Published date: 
1 September 2007
Publication source: 
scopus
Publication type: 
Journal articles
Journal name: 
Drug Discovery Today: Therapeutic Strategies
Publication volume: 
4
Publisher: 
Parent title: 
Edition: 
Publication number: